Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
In Vitro and in Vivo Toxicity and Histopathological Evaluation of Gd(Iii)Anionic Linear Globular Dendrimer Second-Generation G2-C595 Nanoprobe Publisher



Mirzaei M1, 2 ; Akbari ME1 ; Mohagheghi MA3 ; Tavangar SM4 ; Mehravi B5 ; Ardestani MS6
Authors

Source: Nanomedicine Journal Published:2020


Abstract

Objective(s): Toxico-histopathological studies are used to assess the toxic impacts of nanoparticles in organism exposure. The present study aimed to evaluate the prospective nano-cytotoxicity impacts of Gd(III)-anionic linear globular dendrimer second-generation G2-C595 (Gd[III] dendrimer G2-C595) contrast nanoprobe in terms of the exposure of many nude mice organs and organisms. In addition, we assessed the potential of the Gd(III)-dendrimer G2-C595 nanoprobe as a novel magnetic resonance imaging (MRI) nano-contrast agent for the human breast cancer cell line (MCF-7) and human embryonic kidney cell line (HEK-293). Materials and Methods: Gadolinium (Gd[III]) was loaded with dendrimer G2 and conjugated with the C595 monoclonal antibody to generate the Gd(III)-dendrimer G2-C595 to determine the impact on MUC1 beneficial cancer tumors. The cytotoxic effects of the Gd(III)-dendrimer G2-C595 nanoprobe on the HEK-293 cells were also investigated in-vitro and in-vivo. In addition, the Gd(III)-dendrimer G2-C595 nanoprobe was used on nude mice bearing the MCF-7 tumors to explore its specific activity against the in-vivo model of cancer. Results: The Gd(III)-dendrimer G2-C595 contrast nanoprobes affected the cytotoxicity of MCF-7, and no in-vivo toxicity was induced in the HEK-293 cells, kidneys, heart, lungs, brain, liver tissues, and other organs. Conclusion: According to the results, the Gd(III)-dendrimer G2 and Gd(III)-dendrimer G2-C595 induced no toxicity in the HEK-293 cells and heart, liver, and brain tissues of mice. In addition, the Gd(III)-dendrimer G2-C595 showed specific anti-action against the in-vivo tumor model. Therefore, the Gd(III)-dendrimer G2-C595 nanoprobe is highly recommended as a novel and effective MR contrast agent and antitumor carrier agent. Furthermore, the Gd(III)-dendrimer G2-C595 nano-sized probes demonstrated excellent biocompatibility and safety with no impact on normal organ functioning. © Mashhad University of Medical Sciences. All Rights Reserved.
Related Docs
View other Related Docs
1. A Novel Biocompatible Nanoprobe Based on Lipoproteins for Breast Cancer Cell Imaging, Nanomedicine Journal (2020)
2. Properties Evaluation of Gd2o3-Deg As New Contrast Agent Nanomagnetic Particles Comparing to Gd-Dtpa in Mri, IFMBE Proceedings (2015)
3. N-Acetylcysteine-Plga Nano-Conjugate: Effects on Cellular Toxicity and Uptake of Gadopentate Dimeglumine, IET Nanobiotechnology (2020)
Experts (# of related papers)
View all Related Experts
Mehdi Shafee Ardestani (8)
Seyed Esmaeil Sadat Ebrahimi (4)
Other Related Docs
4. Technetium-99M Chelator-Free Radiolabeling of Specific Glutamine Tumor Imaging Nanoprobe: In Vitro and in Vivo Evaluations, International Journal of Nanomedicine (2018)
5. As1411 Aptamer-Anionic Linear Globular Dendrimer G2-Iohexol Selective Nano-Theranostics, Scientific Reports (2017)
6. Gadolinium Nanoparticles As Diagnostic and Therapeutic Agents: Their Delivery Systems in Magnetic Resonance Imaging and Neutron Capture Therapy, Journal of Drug Delivery Science and Technology (2018)
7. Novel Gd-Dtpa-Peptide for Targeted Breast Tumor Magnetic Resonance Imaging, Biomedicine and Pharmacotherapy (2024)
8. Gadolinium (Iii) Oxide Nanoparticles Coated With Folic Acid-Functionalized Poly(Β-Cyclodextrin-Co-Pentetic Acid) As a Biocompatible Targeted Nano-Contrast Agent for Cancer Diagnostic: In Vitro and in Vivo Studies, Magnetic Resonance Materials in Physics# Biology and Medicine (2019)
9. A Biocompatible Theranostic Nanoplatform Based on Magnetic Gadolinium-Chelated Polycyclodextrin: In Vitro and in Vivo Studies, Carbohydrate Polymers (2021)
10. Synthesis and Characterization of Amlodipine-Conjugated Gd3+-Citric Acid Peg Dendrimers for Enhanced Cardiac Mri Contrast, Journal of Molecular Structure (2025)
11. The Assessment of Toxicity Characteristics of Cellular Uptake of Paramagnetic Nanoparticles As a New Magnetic Resonance Imaging Contrast Agent, Iranian Journal of Pharmaceutical Research (2019)
12. Theranostic Rgd@Fe3o4-Au/Gd Nps for the Targeted Radiotherapy and Mr Imaging of Breast Cancer, Cancer Nanotechnology (2023)
13. Gd-Based Nanoparticles Mediated Magnetic Field Enhancement Inside Homogenous Tissue: Simulation Using Finite Element Method, IFMBE Proceedings (2015)
14. 18F-Fdg Micropet and Mri Targeting Breast Cancer Mouse Model With Designed Synthesis Nanoparticles, Journal of Nanomaterials (2022)
15. New Nanoprobe for Breast Cancer Cell Imaging Based on Low-Density Lipoprotein, Artificial Cells# Nanomedicine and Biotechnology (2020)
16. Gd3+-Asparagine-Anionic Linear Globular Dendrimer Second-Generation G2 Complexes: Novel Nanobiohybrid Theranostics, Contrast Media and Molecular Imaging (2017)
17. Folic Acid Decorated Mesoporous Silica Nanospheres Loaded With Gadolinium for Breast Cancer Cell Imaging, Advances in Natural Sciences: Nanoscience and Nanotechnology (2020)
18. Syntehsis and Evaluation of Gd3+ -Trp-Plga As Novel Nanosized Mr Tumor Imaging Candidate, Nanomedicine Journal (2021)
19. Nsf Evaluation of Gadolinium Biodistribution in Renally Impaired Rats: Using Novel Metabolic Gd2o3 Nanoparticles Coated With Β-Cyclodextrin (Gd2o3@Pcd) in Mr Molecular Imaging, Magnetic Resonance Imaging (2024)
20. Gd3+-Dtpa-Bis (N-Methylamine)–Dendrimer Significantly Alters Bax/Bcl2 Gene Expression Levels in Mcf-7 Cancer Cells, Biomedical Research (India) (2017)